Terms: = Uterine cancer AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1 AND Treatment
3 results:
1. Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/β-catenin signaling in cervical cancer.
Yu X; Li Z; Bai R; Tang F
Bioengineered; 2022 May; 13(5):12516-12531. PubMed ID: 35587604
[TBL] [Abstract] [Full Text] [Related]
2. tcf3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer.
Gui T; Liu M; Yao B; Jiang H; Yang D; Li Q; Zeng X; Wang Y; Cao J; Deng Y; Li X; Xu P; Zhou L; Li D; Wang Z; Zen K; Huang DCS; Chen B; Wan G; Zhao Q
Cell Death Differ; 2021 Dec; 28(12):3316-3328. PubMed ID: 34175897
[TBL] [Abstract] [Full Text] [Related]
3. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
[TBL] [Abstract] [Full Text] [Related]
